跳至主要内容
临床试验/NL-OMON24321
NL-OMON24321招募中不适用

sing Continuous Glucose Monitoring and contextual data to increase insight in glucose patterns for individuals with type 2 diabetes

TNO0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • BMI 25 – 40 kg/m2, with preference for < 35 kg/m2
  • Diagnosed with type 2 diabetes mellitus
  • Insulin naïve
  • Using either lifestyle and/or metformin for managing their diabetes
  • In possession of a Smartphone running on a recent version of iOS or Android
  • Able and willing to sign the informed consent form
  • Willing to comply with all study procedures

排除标准

  • Insufficient motivation to be in the study
  • Unavailability for more than 2 weeks in a row during the study period
  • History of bariatric weight loss surgery
  • Planned (bariatric) surgery in the upcoming 6 months
  • Active cancer or chemotherapy or radiation within 2 years prior to participation
  • Chronic medical condition, treatment, or medication other than diabetes that may affect glucose metabolism (HIV diagnosis, use of steroids or immunosuppressive drugs, etc.)
  • Chronic anaemia (haemoglobin of 6.2 mmol/l or less)
  • Use of antibiotics or fertility treatments within 3 months prior to participation
  • Pregnancy or a pregnancy wish
  • 4 or more alcoholic drinks per day on a regular basis or use of recreational drugs
  • Skin allergy, eczema or known sensitivity for plasters
  • Coeliac or Crohns’ disease
  • Food allergies or intolerances including, gluten, wheat, egg, (pea)nuts, celery, sesame, soy, cacao, glutamate, legumes, coriander, maize, (shell)fish, chicken, beef, pork, lamb, sulphites, lupine, milk and lactose

研究者

发起方
TNO

相似试验